RCM
RA Capital Management Portfolio holdings
AUM
$8.12B
1-Year Est. Return
46.06%
1 Year Est. Return
+46.06%
AUM
$5.94B
AUM Growth
-$52.2M
(-0.87%)
Holding
90
Top Buys
| 1 | +$111M | |
| 2 | +$29.3M | |
| 3 | +$27.4M | |
| 4 |
HNGE
Hinge Health
HNGE
|
+$15.5M |
| 5 |
Tyra Biosciences
TYRA
|
+$14.9M |
Top Sells
| 1 | +$58.6M | |
| 2 | +$46.8M | |
| 3 | +$45.6M | |
| 4 |
UroGen Pharma
URGN
|
+$35.5M |
| 5 |
Rhythm Pharmaceuticals
RYTM
|
+$33.1M |
Sector Composition
| 1 | Healthcare | 99.82% |
| 2 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lexeo Therapeutics
LXEO
$547M
| – | – |
-546,554
|
|
||
77
Nurix Therapeutics
NRIX
$1.91B
| – | – |
-1,333,333
|
|
||
78
Scilex Holding
SCLX
$80.6M
| – | – |
-29,606
|
|
||
79
Sera Prognostics
SERA
$136M
| – | – |
-3,032,808
|
|
||
80
Sutro Biopharma
STRO
$111M
| – | – |
-443,464
|
|
||
|
81
UroGen Pharma
URGN
$915M
| – | – |
-3,206,271
|
|
||
82
Xencor
XNCR
$943M
| – | – |
-575,000
|
|
||
83
Zai Lab
ZLAB
$2.09B
| – | – |
-1,295,040
|
|
||
84
Zura Bio
ZURA
$305M
| – | – |
-3,217,503
|
|
||
|
BOLD
85
Boundless Bio
BOLD
$28M
| – | – |
-2,180,631
|
|
||
|
BIOA
86
BioAge Labs
BIOA
$771M
| – | – |
-1,052,494
|
|
||
|
CBLL
87
CeriBell Inc
CBLL
$847M
| – | – |
-824,582
|
|
||
88
Insmed
INSM
$34B
| – | – |
-200,000
|
|
||
|
ITOS
89
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-3,649,057
|
|
||
90
Kura Oncology
KURA
$775M
| – | – |
-4,004,610
|
|